Abstract
A key event in the pathogenesis of Alzheimer's disease is the conversion of soluble amyloid Abeta-peptide into toxic aggregates. Here, we studied the effect of cholesterol depletion on the formation of insoluble Abeta. We found that reduction of neuronal cholesterol by approximately 25% reduced the neuronal formation of insoluble Abeta without affecting the secretion of soluble Abeta. Moreover, we demonstrate that Abeta-oligomers from Alzheimer's disease brains associate with a detergent-resistant membrane fraction in a cholesterol-dependent manner. These results suggest a key role for cholesterol in aggregation of Abeta.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Alzheimer Disease / metabolism*
-
Alzheimer Disease / physiopathology
-
Alzheimer Disease / therapy
-
Amyloid beta-Peptides / metabolism*
-
Animals
-
Cell Membrane / metabolism
-
Cells, Cultured
-
Cholesterol / deficiency*
-
Down-Regulation / physiology
-
Hippocampus / metabolism*
-
Hippocampus / pathology
-
Hippocampus / physiopathology
-
Humans
-
Membrane Lipids / metabolism
-
Membrane Microdomains / metabolism*
-
Mice
-
Middle Aged
-
Neurons / metabolism*
-
Neurons / pathology
-
Plaque, Amyloid / metabolism
-
Plaque, Amyloid / pathology
Substances
-
Amyloid beta-Peptides
-
Membrane Lipids
-
Cholesterol